Congress Agenda

Monday, 28 October 2019

 

        08:00-08:50

Registration

08:50-09:00

Welcome and Opening of the Congress
Congress Chair: Gideon Elkayam, ERPA Chairman, Belgium

09:00-11:30

Session 1: "Yesterday is History, Tomorrow is a Mystery" - A Strategy for Leading Innovation
Moderator: Marta de Oliveira Ferreira, Inovapotek, Portugal

 

09:00-09:30
What is the European Commission Working on?
Izabela Taborska, Legal Officer, European Commission DG Internal Market, Industry, Entrepreneurship and SMEs Unit GROW D.4 "Health Technology & Cosmetics", Belgium

  • Presentation of main topics in the cosmetics sector
 

09:30-10:00
The Regulatory Changes & their Impact
Joëlle Meunier, Coordinator Food Supplements and Cosmetics, Belgian Ministry of Health, Belgium

  • Ingredients in the spotlight
  • Changes to be expected in the near future

 

10:00-10:30
IFRA – the 49th Amendment
Matthias Vey, Scientific Director, IFRA, Belgium

  •  What are the changes?
  • The implementation timeline
  • The implications for the industry
 10:30-11:00
 Coffee Break, Networking and Visit the Exhibition

11:00-11:30
Endocrine Disruptors: Unknown and Unwanted Human Exposure to Exogenic Hormones
Elena Grasselli,
Department of Earth, Environment and Life Sciences, Genoa University, Italy

  •       What are they? Who are they? Why are they problematic?
  •       What is happening now at EC level?

11:30-12:00

Session 2: Is it Magenta or Fuchsia?
Moderator: Marta de Oliveira Ferreira, Inovapotek, Portugal

 

11:30-12:00
Borderline Products
Gerald Renner, Director Technical Regulatory Affairs, Cosmetics Europe, Belgium

  • Is your product considered a cosmetic in the EU?
  • How to classify borderline products?
  • Classical borderline products wrongly classified
  • Hint and tricks in product classification
  • Are products sometimes purposely wrongly classified due to commercial matters?
  • Examples of court cases involving cosmetics
  • When do manufacturers go to court?
 12:00-12:30  
Session 3: The Core
Moderator: Marta de Oliveira FerreiraInovapotek, Portugal


12:00-12:30

Can New Generation Risk Assessment (NGRA) be the Answer for Safe Animal-Free Cosmetic Ingredients?
Vera Rogiers,
Professor, Vrije Universiteit Brussels, Belgium
  •      What is new?
  •      Next Generation Risk Assessments (NGRA)

12:30-13:30
13:00-13:30

Lunch Break, Networking and Visit the Exhibition
One-to-One Meetings with Speakers

13:30-14:00

Session 4: Passport to other Markets
Moderator: Alina Nanu, Eurofins, Romania

 


13:30-14:00
Free Sales Certificates
Peter Bursch,
CoSIChem, Germany
  • What are they?
  • Why do you need them?
  • How to obtain one?

14:00-14:30

Session 5: Just a Click Away
Moderator: Alina Nanu, Eurofins, Romania

14:00-14:30
Players of the Online Field
Els Vrindts, Inspector Officer and Coordinator, Belgian Competent Authorities, SPF Sante Publique, Securite de la Chaine Alimentaire et Environnement, Belgian

  • Who is responsible for compliancy online?
  • How are the European Competent Authorities ensuring compliancy online?
  • How is the responsible person ensuring compliancy online?
  • Best practices
 

14:30-15:30



Session 6: The Sky is the Limit
Moderator: Alina Nanu, Eurofins, Romania

14:30-15:00

Microbiome
Ana Palmeira de Oliveira, General Manager, Labfit, Portugal

  • What is it?
  • Is it trendy now? Why?
  • What is true and what is pure marketing?
   

15:00-15:30
Crème a la crème

Guido Rainis, Consultant RA Cosmetics, MDSS, Germany

  • Natural ingredients and compliancy
  • What should you consider when using natural ingredients? The challenges
  • Are regulatory wise natural products different than the others?
  • CBD vs. THC: What is the difference?

15:30-16:00

Coffee Break, Networking and Visit the Exhibition

16:00-16:30

Session 7: How do your Partners Affect your Business?
Moderator: Alina Nanu, Eurofins, Romania

   

16:00-16:30
The Compliance to the GMP beyond the Certification
Matteo Zanotti Russo, 
CEO, Angel Consulting, Italy

  • Beyond the certification
  • The hidden link between GMP and CPSR
  • GMP in practice: How to assess cosmetic products made on the other side of the planet?

      16:30

End of Day One

Tuesday, 29 October 2019

        08:30-09:00

Registration

09:00-10:45

Session 8: See EU Later, Alligator!
Moderator: Gideon Elkayam, Obelis, Belgium

   

09:00-09:45
Brexit - The Good, the Bad and the Ugly
Sandra Ferretti, CCO & Public Affairs Manager, Obelis, Belgium
Daniel Burney, Regulatory Chemist and Cosmetic Safety Assessor, MSL,UK

  • Background
  • Current situation
  • Implications for cosmetics manufacturers
  • Regulatory compliancy implications

09:45-10:45

Brexit Panel
Daniel Burney, Regulatory Chemist and Cosmetic Safety Assessor, MSL,UK
Sandra FerrettiChief Compliance Officer & Public Affairs Manager, Obelis, Belgium
Ludger MoellerCEO, Medical Device Safety Service, Germany

  •   Future implications
  •   Benefits vs. disadvantages

 10:45-11:15
  Coffee Break
 11:15-11:30
  Networking and Visit the Exhibition

11:30-12:00

Session 9: Good Things Come is Small Packages?
Moderator: Gideon Elkayam, Obelis, Belgium

 

11:30-12:00
Where are we with Nanomaterials in Cosmetics?
David Carlander, Nanotechnology Industries Association, Belgium

  • What has been done so far in regard to nanomaterials in cosmetics?
  • What nanomaterials are allowed in cosmetics?
  • How to have your nanomaterial approved to be used in cosmetic products?
  • What are the benefits and disadvantages of nanomaterials?

12:00-13:00

Session 10: Claims, Claims and Some More Claims
Moderator: Gideon Elkayam, Obelis, Belgium

 

 

 

 

 

12:00-12:30
10 Things that you should Know before Starting a Clinical Trial
Alina Nanu, General Manager, Eurofins Evic Product Testing, Romania

  • What is allowed and what is not?
  • How much proof of claim is needed?
  • What is appropriate proof of claim?
  • What is safety and what is commercial?
  • Do simple claims not sell anymore?

 

12:30-13:00
How "To Run with the Hare and Hunt with the Hounds"?
Marta de Oliveira Ferreira, General Manager, Inovapotek, Portugal

  • The truth about controversial claims, the authorities view
  • The bunny symbol, "Free off", "Vegan", "Natural",...
  • What is the regulatory impact for these claims?
  • Do EU authorities have different approaches?

13:00-14:00
13:30-14:00

Lunch Break, Networking and Visit the Exhibition
One-to-One Meetings with Speakers

14:00-15:30

Session 11: The Technical Side
Moderator: Peter Bursch, CoSIChem, Germany

   

14:00-14:30
PIF Data Management
Jasper ten Brinke, 
The Regulatory Company, The Netherlands

  • Key PIF aspects and elements
  • The central role of the PIF in regulatory processes
  • Examples of product formula changes and more, and their impact on the PIF and PIF elements
  • A best practice PIF management concept with great efficiency benefits and high value adds

 


14:30-15:00
Analytical Requirements of Cosmetics
Yiannis Kapetanstratakis, Manager of Safety and Efficacy Department, QACS, Greece
  •  What is new?
  • Allergens
  • Migration
  • NGS (New Generation Sequencer) for micro identification

 

15:00-15:30
Cosmetics Packaging Material
Stephane Pirnay,
CEO, Expertox, France

  • Technical requirements
  • Why is packaging information so scarce?
  • Missing Information: analytical strategies and new guideline
 15:30-16:00
 Coffee Break, Networking and Visit the Exhibition

16:00-17:00

Session 12: Vigilance / PMS / Authorities Controls
Moderator: Peter Bursch, CoSIChem, Germany

 

16:00-16:30
Post Market Surveillance
Ludger Moeller, CEO, Medical Device Safety Service, Germany

  • What does PMS mean?
  • Can I avoid PMS?
  • Procedures? Are they helpful?
  • What kind of consumer events need to be notified to the authorities (Cosmetovigilance)
  • Market Surveillance. Hopefully it will not happen! What could this mean to your product or company

   
16:30-17:00
The Usual Suspects on the Cosmetic Market
Els Vrindts, Inspector Officer and Coordinator, Belgian Competent Authorities, SPF Sante Publique, Securite de la Chaine Alimentaire et Environnement, Belgian
  • Common irregularities identified during inspections and how to avoid them
  • Examples include non-compliant ingredients and non-conpliant claims and the CBD or cannabis products

 17:00

Congress Closing Remarks
Congress Chair: Gideon Elkayam, ERPA Chairman